US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Noom Inc
Noom Study Finds Members Further Along in Its GLP-1Rx Program Report Higher “Flourishing” and “Quality of Life”
October 28, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Appoints Jim Bugden Chief Financial Officer as Company Enters Next Phase of Growth
August 18, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience
July 29, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Launches 'Lose for Keeps' with Rebel Wilson, a New Campaign Making the Case That GLP-1 Medication and Healthy Habits Work Better Together
July 20, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Launches Free Version of Its Powerful GLP-1 Companion — Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts
June 24, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show
June 24, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Brings the Lab to the Living Room: New At-Home Biomarkers Test Kit Enables Members to See Exactly How GLP-1s and Healthy Habits Are Transforming Their Health
May 27, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Names “Power of Habit” Author Charles Duhigg as Advisor, Releases New Research Linking GLP-1 Success to Habit Formation
May 05, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Health’s SmartRx Program on Track to Cut Employer’s GLP-1 Spend by Nearly 80%
April 23, 2026
From
Noom Inc
Via
GlobeNewswire
Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members
April 09, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health
April 01, 2026
From
Noom Inc
Via
GlobeNewswire
Former Peloton and Equinox Design Leader Cecilia Farooqi Joins Noom as Head of Product Design
March 17, 2026
From
Noom Inc
Via
GlobeNewswire
The Noom Engagement Report: New Data Shows that the GLP-1 Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest
February 04, 2026
From
Noom Inc
Via
GlobeNewswire
Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease
December 15, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
November 06, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
October 20, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Introduces “Mindful Art Break” — A Weekly Practice Designed to Spark Awe, Relieve Stress, and Boost Psychological Wellbeing
October 15, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Welcomes Rebel Wilson as Chief Wellness Ambassador to Champion Microhabits and Microdose GLP-1s
September 18, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program
August 04, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Invited to White House to Pledge to the CMS Digital Health Ecosystem Shared Framework Empowering People, Integrating AI, and Accelerating Healthcare Access
July 30, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Expands Board of Directors with Appointment of Global Health Leader Dr. David Luu
June 10, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Launches Free Menopause Education Hub in Partnership with Menopause Advocate Tamsen Fadal
May 30, 2025
From
Noom Inc
Via
GlobeNewswire
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
April 07, 2025
From
Noom Inc
Via
GlobeNewswire
Noom To Streamline Access to Zepbound® Vials with Noom GLP-1 Companion Through Integration with LillyDirect® Pharmacy Provider
March 31, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Expands into Hormone Replacement Therapy to Support Women’s Health and Well-being
February 28, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
January 22, 2025
From
Noom Inc
Via
GlobeNewswire
Noom’s GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model
January 14, 2025
From
Noom Inc
Via
GlobeNewswire
Noom Offers Oral Medications For Weight Loss Starting at $29
December 12, 2024
From
Noom Inc
Via
GlobeNewswire
Noom Unveils Two New Enterprise Products to Help Employers Offer, Manage, and Effectively Control GLP-1 Expenses
October 21, 2024
From
Noom Inc
Via
GlobeNewswire
Noom Introduces Innovative In-App Body Scan Technology to Monitor Muscle-Mass Retention During GLP-1 Treatment
October 17, 2024
From
Noom Inc
Via
GlobeNewswire
